Loading...
Inogen, Inc.
INGN•NASDAQ
Healthcare
Medical - Devices
$6.80
$0.00(0.00%)
Inogen, Inc. (INGN) Financial Performance & Income Statement Overview
Review Inogen, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.35%
↑ 6.35%
Operating Income Growth
61.13%
↑ 61.13%
Net Income Growth
64.97%
↑ 64.97%
Operating Cash Flow Growth
282.87%
↑ 282.87%
Operating Margin
-9.67%
↓ 9.67%
Gross Margin
45.64%
↑ 45.64%
Net Profit Margin
-8.08%
↓ 8.08%
ROE
-14.76%
↓ 14.76%
ROIC
-13.53%
↓ 13.53%
Inogen, Inc. (INGN) Income Statement & Financial Overview
Review Inogen, Inc.'s (INGN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $80.08M | $88.83M | $88.77M | $78.03M |
| Cost of Revenue | $43.79M | $47.49M | $41.62M | $44.59M |
| Gross Profit | $36.29M | $41.34M | $47.15M | $33.44M |
| Gross Profit Ratio | $0.45 | $0.47 | $0.53 | $0.43 |
| R&D Expenses | $5.90M | $3.52M | $4.43M | $5.65M |
| SG&A Expenses | $41.78M | $45.62M | $43.16M | $43.26M |
| Operating Expenses | $47.67M | $49.14M | $53.19M | $48.91M |
| Total Costs & Expenses | $91.47M | $96.63M | $94.80M | $93.49M |
| Interest Income | $1.41M | $1.04M | $1.33M | $1.40M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $5.08M | $0.00 | $5.34M | $5.26M |
| EBITDA | -$6.31M | -$7.79M | -$1.30M | -$10.20M |
| EBITDA Ratio | -$0.08 | -$0.09 | -$0.01 | -$0.13 |
| Operating Income | -$11.39M | -$7.79M | -$6.04M | -$15.47M |
| Operating Income Ratio | -$0.14 | -$0.09 | -$0.07 | -$0.20 |
| Other Income/Expenses (Net) | $1.30M | $1.73M | $1.47M | $1.55M |
| Income Before Tax | -$10.09M | -$6.06M | -$5.60M | -$14.73M |
| Income Before Tax Ratio | -$0.13 | -$0.07 | -$0.06 | -$0.19 |
| Income Tax Expense | -$330000.00 | -$101000.00 | -$7000.00 | -$150000.00 |
| Net Income | -$9.76M | -$5.96M | -$5.59M | -$14.58M |
| Net Income Ratio | -$0.12 | -$0.07 | -$0.06 | -$0.19 |
| EPS | -$0.41 | -$0.25 | -$0.24 | -$0.62 |
| Diluted EPS | -$0.41 | -$0.25 | -$0.24 | -$0.62 |
| Weighted Avg Shares Outstanding | $23.85M | $23.75M | $23.61M | $23.40M |
| Weighted Avg Shares Outstanding (Diluted) | $23.85M | $23.75M | $23.61M | $23.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan